Cyclobenzaprine
A centrally acting muscle relaxant structurally related to tricyclic antidepressants that relieves muscle spasm and associated pain by acting on the brain stem. It is used short-term for acute musculoskeletal conditions and should not be used for more than two to three weeks.
Moleküler Ağırlık
275,4000 g/mol
LogP
5,20
TPSA
3,20 Ų
Lipinski RO5
Geçer
Terapötik Alanlar
Etki Mekanizması
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
2D Yapı
Cite this structure
Embed this structure
SMILES
CN(C)CCC=C1c2ccccc2C=Cc2ccccc21
InChI
InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3
Molecular Formula
C20H21N
HBD / HBA
- / 1
Döndürülebilir Bağlar
3
Ağır Atomlar
21
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
A centrally acting muscle relaxant structurally related to tricyclic antidepressants that relieves muscle spasm and associated pain by acting on the brain stem. It is used short-term for acute musculoskeletal conditions and should not be used for more than two to three weeks.
Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.
Yes, Cyclobenzaprine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL669. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2895. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="cyclobenzaprine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/cyclobenzaprine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/cyclobenzaprine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/cyclobenzaprine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="cyclobenzaprine"></drugfyi-drug>